TIDMTLY
RNS Number : 8312U
Totally PLC
28 November 2023
28 November 2023
Totally plc
("Totally", "the Company" or "the Group")
Interim results for the six months ended 30 September 2023
Responding to an evolving market - supporting the NHS during
their challenging times
Totally plc (AIM: TLY), a leading provider of frontline
healthcare services, corporate fitness and wellbeing services
across the UK and Ireland , is pleased to announce its unaudited
interim results for the six months ended 30 September 2023.
Financial highlights
-- Group turnover down 20.6% to GBP55.8 million (H1 2023: GBP70.3 million).
-- Gross profit down 18.5% to GBP9.7 million (H1 2023: GBP11.9 million).
-- EBITDA excluding exceptional items GBP1.1 million (H1 2023: GBP3.4 million).
-- Exceptional items of GBP0.5 million relating to restructuring costs (H1 2023: nil).
-- Loss before tax of GBP1.9 million (H1 2023: GBP1.0 million profit before tax ).
-- Adjusted loss before tax of GBP1.0 million (H1 2023: GBP2.0 million profit before tax).
-- Cash position of GBP1.7 million at 30 September 2023 (31 March 2023: GBP6.5 million).
-- No interim dividend proposed at this time (H1 2023: 0.125p).
-- New contracts secured in the period contributing GBP14.8 million of annualised revenue.
Operational highlights
-- Totally continues to support the NHS and healthcare providers
across the UK and in the Republic of Ireland with the delivery of
urgent and elective care services across multiple locations,
ensuring that patients can access the appropriate care, when they
need it.
-- Totally has responded robustly to challenging market
conditions by taking responsible action to reduce overhead and
rationalise operational infrastructure.
-- Group is well positioned to return to profitability following
rationalisation of contracts, careful management of increasing
costs and reduced support costs.
-- New contracts worth c.GBP2.3 million in the current financial
year awarded to support the reduction of elective care waiting
lists in the Republic of Ireland.
-- Fully mobilised GBP10 million contract announced in January
2023 for NHS England 111 Resilience support. Post period additional
capacity mobilised to ensure resilience during winter months.
-- Successful pilots with multiple ambulance trusts to broaden
access to care for all types of patient.
-- All Care Quality Commission (CQC) registerable services
continue to be rated as GOOD reflecting Totally's commitment to
excellent patient care during continued pressure across the
healthcare industry.
Chairman's statement
I am pleased to announce trading results for the six months
ended 30 September 2023. My AGM announcement in early September
highlighted the challenging operating environment that the Group
was facing, with increasing costs and difficulties in hiring
suitably qualified teams of people.
The NHS continues to be in crisis, and this impacts all
organisations that are there to support them. The loss of North
West London contracts resulted in a downturn in our revenues in the
period being reported. As the contracts came to the end of their
contracted period, and despite previous assertions that we would
retain the contracts, the ICB allowed the contracts to end. We were
unable to terminate all costs immediately at that point but have
since undertaken a significant cost review to remove costs related
to those contracts as well as other costs which are not critical to
the day to day running of the business.
Totally prides itself on being able to support the NHS by
looking after those patients who do not have life critical
conditions, meaning that the NHS can focus on those patients that
only it can treat. We remain ready to provide support where it is
needed and we are confident that we will return to growth. This
approach reflects the professionalism and commitment to patient
care with which the Company delivers all its services.
During the first half of the year, we have participated in a
number of pilots with ambulance trusts to identify ways to increase
access to care for all types of patients. We are very positive
about the outcomes of these pilots and the potential to support
trusts on a longer-term basis. We also continue to tender for
opportunities to run urgent care services on behalf of the NHS and
to reduce elective care waiting lists through both insourcing and
outsourcing. We are continuing to see delays in the conclusion of
procurement processes, but we are confident in the quality of our
tenders, our services and the future prospects for the Group.
The scale of the opportunity for the Company remains significant
and we remain confident that the NHS will rebound, survive and
thrive once more, with the support of organisations such as
Totally.
In line with corporate governance requirements, having spent
nine years as a Director of Totally, I will step down from the
Board at the end of 2023. I am pleased to confirm that Simon
Stilwell will be joining our Board as a non-executive director
effective today and taking over as Chairman of Totally plc from 1
January 2024. The Company intends to make further Board changes
over the coming months in line with best corporate governance
standards.
Once again, I want to pass my ongoing thanks to our exceptional
teams who continue to deliver essential services alongside NHS
colleagues under incredible pressure. Totally is able to provide
excellent and compassionate services to thousands of individuals
across the UK and Ireland every day due to the commitment,
expertise and passion of our teams.
Bob Holt OBE
Chairman
28 November 2023
Operational review
It has been a challenging first six months of the year as we
continue to respond to multiple external factors such as high
inflation, an NHS in crisis and workforce shortages. We have
continued to work with NHS colleagues to maintain effective
services and seek new innovative ways to support demand. Demand for
healthcare remains high and will increase as winter months
bite.
External pressures have impacted the Group in the first half of
the period, to which we have responded accordingly, quickly
reorganising our operating and corporate structure to reflect the
changing shape of the business, whilst ensuring we retain capacity
to grow. We delivered GBP0.5 million of cost savings in the first
half of the year with increased savings to be delivered in the
second half, as further efficiencies from structural changes are
realised. In total, c.GBP3.0 million of annual costs have been
removed from our overheads and we continue to ensure our
infrastructure is fit for purpose.
As with most businesses we manage our cash facilities on a daily
basis. The cash balance at the end of September was adversely
affected by a GBP2.9m NHS debtor which was paid shortly after
period end. The Board expects the Company to be cash positive in
H2.
As we enter what is traditionally the busiest period of the year
for healthcare, there are opportunities to further expand support
for resilience services and we are working to ensure that we retain
the capacity within the organisation to meet demand. We have
recently mobilised additional capacity for NHS England 111
Resilience work, in addition to our continuing 111 contract as NHS
England's Resilience partner (mobilised in April and valued at
GBP10 million). During October 2023 we delivered considerable
additional capacity demonstrating our ability to respond rapidly to
increased demand. The additional capacity agreed for the period 1
October and 2023 to 31 March 2023 has the potential to double the
revenue originally confirmed for the original NHS 111 resilience
contract.
All of the services we deliver on behalf of NHS England and NHS
trusts continue to perform well.
Urgent Care
Totally's Urgent Care continues to deliver core services on
behalf of the NHS across the UK, including Urgent treatment
centres, GP out-of-hours, clinical assessment services, and online
and telephonic 111 services. We expect to support thousands of
people with access to the healthcare they need during over the
forthcoming winter.
Our focus on delivering excellent, quality care continues and a
s a result, all of Totally's CQC registerable services continue to
be rated as GOOD.
During the period our work on adapting services, innovating
current and new services as well as taking forward our thoughts on
increasing the use of digital services continued at pace. We have
also worked closely with a number of ambulance trusts to identify
and test new ways to broaden access and support for all types of
patients. Ongoing pilots have been extremely successful and we are
positive about the potential to work more extensively with these
trusts as we move forward.
Elective Care
Demand for elective care remains high, with the number of
patients waiting for care at all-time highs, as reported widely in
the media. Totally continues to be registered as an approved
provider on frameworks targeting waiting reduction across the UK
and Ireland.
Energy Fitness Professionals
During the period, Energy Fitness Professional has been
responding to increased tender opportunities, including
opportunities to deliver services in partnerships with Totally
healthcare operations.
During November 2023 the deferred consideration of GBP0.3
million, in relation to the acquisition Energy Fitness
Professionals on 16 December 2021, was paid.
Outlook
It is a difficult time for all healthcare provider organisations
however, managing demand and controlling costs is not a new
challenge for Totally and is one that we have faced and responded
to for many years. We have taken significant action to reduce costs
as we respond to the current market conditions and will continue to
seek out and identify new opportunities to drive efficiencies as
part of our business-as-usual cost management processes.
We are confident that our strong cost management culture will
enable us to return to previous levels of profit in future years,
whilst recognising the potential for lower revenues. Due to the
ongoing challenges however, the Board of Totally believe it is
prudent at the present time to withdraw market forecasts until such
time as normal market conditions return. As previously stated, the
Board is confident in the medium to long term prospects of the
business but views the current financial year as a period of
re-structuring and working alongside the NHS to manage current
issues. The Board will seek to provide forward looking growth
targets at the appropriate time.
Despite the recognised uncertainties that once again come with
the winter period, we remain confident that the business is
well-positioned. The NHS is in crisis and issues with their
workforce still need addressing. This inevitably results in
uncertainty for commissioners and delays important decisions
required for them to meet ongoing demand. Nevertheless, we are
confident that the financial challenges being currently experienced
by the NHS and those associated with it will be resolved. By
working together, continuing to seek new ways of working, such as
the recent pilots undertaken with ambulance trusts and the
development of new models of care, which reflect the needs of
today's population, we can help ensure the delivery of excellent
patient care and return to growth.
I would like to thank our team for their continued hard work and
commitment. All colleagues across Totally are committed to ensure
that patients receive the very best care they can and are
delivering this under exceptional circumstances. Similarly, we
thank our shareholders for their continued support, and look
forward to updating the market on new opportunities in due
course.
Wendy Lawrence
Chief Executive Officer
28 November 2023
Investor presentation
Wendy Lawrence, Chief Executive Officer, Lisa Barter, Chief
Financial Officer, and John McMullan, Medical Director will provide
a live presentation relating to the Company's interim results via
the Investor Meet Company at 11:00 a.m. (UK) on Thursday, 30
November 2023. The online presentation is open to all existing and
potential shareholders and will consist of a presentation followed
by a Q&A session. Questions can be submitted pre-event via the
Investor Meet Company dashboard or at any time during the live
presentation.
Investors can sign up to Investor Meet Company for free and add
to meet Totally plc via:
https://www.investormeetcompany.com/totally-plc/register-investor
Investors who already follow Totally plc on the Investor Meet
Company platform will automatically be invited.
For further information please contact:
Totally plc
Wendy Lawrence, Chief Executive
Bob Holt, Chairman
Holly Smart, Director of Communications
& Marketing 020 3866 3330
Canaccord Genuity Limited (Nominated Adviser
& Corporate Broker)
Bobbie Hilliam
Harry Rees 020 7523 8000
Notes to editors
About Totally
Totally is a leading provider of healthcare and wellbeing
services across the UK and Ireland, working in partnership with the
NHS, other healthcare providers and corporate customers to help
address the challenges of increased demand for healthcare
services.
The Company is committed to pursuing a progressive buy-and-build
consolidation strategy within the fragmented healthcare market and
looks to capitalise on the attractive opportunities that its
disruptive service model offers to generate value to
shareholders.
Totally helps healthcare commissioners and hospitals ensure
patients can access the most appropriate care quickly and
efficiently by delivering quality urgent care services, such as NHS
111 and urgent treatment centres, elective care services including
insourcing, outsourcing and elective care delivered via 'Any
Qualified provider', as well as community dermatology clinics; and
therapy servicing including first contact practitioner and a full
physiotherapy and podiatry offering. Our corporate customer
services also play a role in reducing reliance on healthcare by
promoting healthy lifestyles and physical and mental health.
Healthcare services
Urgent Care: Totally's urgent care services are delivered under
the Totally Urgent Care brand, by Vocare and Greenbrook Healthcare.
Both businesses have a strong heritage and have been delivering
quality urgent care services including NHS 111, GP Out of Hours and
Urgent Treatment centres on behalf of the NHS for more than 25
years and 15 years respectively.
Elective care: Totally's elective care services are delivered by
Pioneer Healthcare, About Health and Premier Physical
Healthcare.
-- Pioneer Healthcare was established in 2007 and delivers a
wide range of acute services to NHS patients, in partnership with
independent healthcare sector private hospitals across England, to
help the NHS reduce waiting lists whilst maintaining patient care
and quality. Pioneer offer services through insourcing and
outsourcing agreements and through its Any Qualified Provider
status.
-- About Health has been delivering community-based specialist
care with a focus on delivering prompt assessment and treatment
across the country since 2008.
-- Premier Physical Healthcare was established in 2007 and
provides physiotherapy and podiatry services to NHS patients, often
within a community GP practice, and to the prison service.
Corporate Wellbeing Services
Energy Fitness Professionals ("EFP"): EFP is a corporate fitness
provider established in 1990 to address a gap in the market for
workplace fitness, which has grown to offer a range of services
covering workplace wellbeing. EFP manages 58 gyms on behalf of its
corporate customers, with more than 11,500 members.
For more information visit www.totallyplc.com
Interim Consolidated Income Statement
For the six months ended 30 September 2023
Six Months Six Months Year ended
ended 30 September ended 30 September 31 March
2023 2022 2023
(unaudited) (unaudited) (audited)
GBP000 GBP000 GBP000
------------------------------ ------------------- ------------------- -----------
Revenue 55,802 70,300 135,696
Cost of sales (46,114) (58,376) (110,695)
------------------- ------------------- -----------
Gross profit 9,688 11,924 25,001
Administrative expenses (8,569) (8,516) (18,113)
Other income - - 2
Exceptional items (475) - (562)
EBITDA 644 3,408 6,328
Depreciation and amortisation (2,254) (2,249) (4,249)
------------------- ------------------- -----------
Operating profit (1,610) 1,159 2,079
Finance costs (257) (119) (295)
------------------- ------------------- -----------
Profit before tax (1,867) 1,040 1,784
Income tax - (150) -
------------------- ------------------- -----------
Profit after tax (1,867) 890 1,784
------------------- ------------------- -----------
Earnings per share
Basic: Pence (0.95) 0.48 0.94
Diluted: Pence (0.95) 0.47 0.93
Adjusted Earnings per share
Basic: Pence (0.50) 1.06 1.99
Diluted: Pence (0.50) 1.05 1.96
All activities relate to continuing operations.
Interim Consolidated Statement of Changes in Equity
For the six months ended 30 September 2023
Share capital Share premium Retained Equity Shareholders'
earnings funds
GBP000 GBP000 GBP000
GBP000
------------------------------------ ------------- ------------- --------- --------------------
At 1 April 2023 (Audited) 19,610 1,945 15,510 37,065
Comprehensive loss for the period
(Unaudited) - - (1,867) (1,867)
Issue of share capital (Unaudited) 45 - - 45
At 30 September 2023 (Unaudited) 19,655 1,945 13,643 35,243
------------- ------------- --------- --------------------
At 1 April 2022 (Audited) 18,723 1,053 15,634 35,410
Comprehensive profit for the period
(Audited) - - 1,784 1,784
Issue of share capital (Audited) 887 892 - 1,779
Dividend payment (Audited) - - (1,908) (1,908)
At 31 March 2023 (Audited) 19,610 1,945 15,510 37,065
------------- ------------- --------- --------------------
At 1 April 2022 (Audited) 18,723 1,053 15,634 35,410
Comprehensive profit for the period
(Unaudited) - - 890 890
Credit on issue of warrants and
options (Unaudited) - - 61 61
------------- ------------- --------- --------------------
At 30 September 2022 (Unaudited) 18,723 1,053 16,585 36,361
------------- ------------- --------- --------------------
Interim Consolidated Statement of Financial Position
As at 30 September 2023
Six Months Six Months Year ended
ended 30 ended 30 31 March
September September 2023
2023 2022
(unaudited) (unaudited) (audited)
GBP000 GBP000 GBP000
----------------------------------- ------------ ------------ ----------
Non-current assets
Intangible fixed assets 46,641 48,492 48,210
Property, plant and equipment 1,107 1,295 1,218
Right-of-use assets 2,689 1,526 1,362
Deferred tax 242 363 242
------------ ------------ ----------
Total non-current assets 50,679 51,676 51,032
Current assets
Inventories 72 72 75
Trade and other receivables 16,609 17,547 13,680
Cash and cash equivalents 1,704 7,441 6,451
------------ ------------ ----------
Total current assets 18,385 25,060 20,206
------------ ------------ ----------
Total assets 69,064 76,736 71,238
------------ ------------ ----------
Current liabilities
Trade and other payables (26,753) (31,093) (28,057)
Borrowings (2,500) - (2,500)
Lease liabilities (508) (275) (275)
Deferred acquisition consideration (528) (6,636) (528)
------------ ------------ ----------
Total current liabilities (30,289) (38,004) (31,360)
Non-current liabilities
Lease liabilities (2,311) (1,778) (1,661)
Other payables (209) (47) (140)
Deferred tax (1,012) (546) (1,012)
------------ ------------ ----------
Total non-current liabilities (3,532) (2,371) (2,813)
------------ ------------ ----------
Total liabilities (33,821) (40,375) (34,173)
------------ ------------ ----------
Net current liabilities (15,436) (15,315) (11,154)
------------ ------------ ----------
Net assets 35,243 36,361 37,065
------------ ------------ ----------
Shareholders' Equity
Share capital 19,655 18,723 19,610
Share premium account 1,945 1,053 1,945
Retained earnings 13,643 16,585 15,510
------------ ------------ ----------
Equity shareholders' funds 35,243 36,361 37,065
------------ ------------ ----------
Interim Consolidated Cash Flow Statement
For the six months ended 30 September 2023
Six Months Six Months Year ended
ended 30 September 31 March
2023 2023
(unaudited) ended 30 September (audited)
2022
GBP000 (unaudited) GBP000
GBP000
------------------------------------- ------------------- -------------------- -----------
Cash flow from operating activities:
(Loss)/profit before tax (1,867) 1,040 1,784
Adjustments for:
Options and warrants charge - 61 -
Amortisation and depreciation 2,254 2,249 4,249
Loss on disposal of non-current
assets - - 33
Finance Income - - (26)
Finance costs 257 119 321
Movements in working capital:
Movement in inventory 3 2 (1)
Movement in trade and other
receivables (2,929) (4,512) 419
Movement in trade and other
payables (1,554) (5,186) (8,106)
------------------- -------------------- -----------
Cash (used in)/generated from
operations (3,836) (6,227) (1,327)
Income tax received/(paid) - - (280)
------------------- -------------------- -----------
Net cash flows from operating
activities (3,836) (6,227) (1,607)
------------------- -------------------- -----------
Cash flow from investing activities:
Purchase of property, plant
and equipment (224) (400) (730)
Additions of intangible assets (114) (305) (665)
Contingent consideration - - (4,896)
Acquisition of subsidiary, net
of cash acquired - - (735)
------------------- -------------------- -----------
Net cash flows from investing
activities (338) (705) (7,026)
------------------- -------------------- -----------
Cash (outflow)/inflow before
financing (4,174) (6,932) (8,633)
Cash flow from financing activities:
Issue of share capital 45 - 567
Dividends paid - - (1,908)
Borrowings - - 2,500
Interest paid (188) (119) (295)
Finance lease payments (430) (819) (1,091)
------------------- -------------------- -----------
Net cash flow from financing
activities (573) (938) (227)
------------------- -------------------- -----------
Net decrease in cash and cash
equivalents (4,747) (7,870) (8,860)
Cash and cash equivalents at
beginning of the period 6,451 15,311 15,311
------------------- -------------------- -----------
Cash and cash equivalents at
end of the period 1,704 7,441 6,451
------------------- -------------------- -----------
Notes to the Interim Results
1. Basis of preparation
Totally plc is a public limited company incorporated in the
United Kingdom under the Companies Act 2006 (registration number:
3870101). The Company's ordinary shares are admitted to trading on
the AIM market of the London Stock Exchange ("AIM").
The Group's principal activities in the period under review have
been the provision of innovative and consolidatory solutions to the
healthcare sector, which are provided by the Group's wholly owned
subsidiaries, Totally Health Limited, Premier Physical Healthcare
Limited, About Health Limited, Optimum Sports Performance Centre
Limited, Vocare Limited, Greenbrook Healthcare (Hounslow) Limited,
Greenbrook Healthcare (Earl's Court) Limited, Totally Healthcare
Limited, Pioneer Health Care Limited and Energy Fitness
Professionals Limited.
The Group's interim report and accounts for the six months ended
30 September 2023 have been prepared using the recognition and
measurement principles of International Accounting Standards in
conformity with the requirements of the Companies Act 2006 as per
the annual report.
These interim financial statements for the six months ended 30
September 2023 have been prepared in accordance with the AIM Rules
for Companies and should be read in conjunction with the financial
statements for the year ended 31 March 2023, which have been
prepared in accordance with International Accounting Standards in
conformity with the requirements of the Companies Act 2006 as per
the annual report. The interim report and the condensed financial
statements do not include all the information and disclosures
required in the annual financial statements.
The interim report and condensed financial statements have been
prepared on the basis of the accounting policies, presentation and
methods of computation as set out in the Group's March 2023 Annual
Report and Accounts and on the basis of the principal accounting
policies that the Group expects to apply in its financial
statements for the year ending 31 March 2024.
The interim report and condensed financial statements do not
comprise statutory accounts within the meaning of section 434 of
the Companies Act 2006. These interim financial statements were
approved by the Board of Directors on 14 November 2023. The results
for the six months to 30 September 2023 and the comparative results
for the six months to 30 September 2022 are unaudited. The amounts
for the period ended 31 March 2023 are extracted from the audited
statutory financial statements of the Group for that period.
The Directors believe that a combination of the Group's current
cash and credit facilities, projected revenues from existing and
future contracts will enable the Group to meet its obligations and
to implement its business plan in full. Inherently, there can be no
certainty in these matters, but the Directors believe that the
Group's internal trading forecasts are realistic and that the going
concern basis of preparation continues to be appropriate.
2. Earnings per share
Basic earnings per share is calculated by dividing the
(loss)/profit attributable to equity holders of the Company by the
weighted average number of ordinary shares in issue during the
period. Diluted earnings per share takes into account the effects
of share options in issue.
Adjusted earnings per share is calculated by dividing the
pre-exceptional (loss)/profit before amortisation of intangible
customer contracts & relationships and tax by the weighted
average number of ordinary shares in issue during the period.
Statutory Earnings per 6 months ended 6 months ended Year ended
share 31 March 2023
30 September 30 September GBP000
2023 2022
GBP000 GBP000 (Audited)
(Unaudited) (Unaudited)
Profit (GBP000) (1,867) 890 1,784
Weighted average number
of shares used in basic
earnings per share calculations
('000) 196,547 187,268 190,836
Potentially dilutive share
options and contingent share
consideration ('000) 144 2,070 3,238
---------------- ---------------- -----------------
Weighted average number
of shares used in diluted
earnings per share calculations
('000) 196,691 189,338 194,074
---------------- ---------------- -----------------
Basic earnings per share
(Pence) (0.95) 0.48 0.94
Diluted earnings per share
(Pence) (0.95) 0.47 0.93
---------------- ---------------- -----------------
Adjusted Earnings per 6 months ended 6 months ended Year ended
share 31 March
2023
30 September 30 September GBP000
2023 2022
GBP000 GBP000 (Audited)
(Unaudited) (Unaudited)
Pre-exceptional profit
before tax (GBP000) (1,867) 1,040 2,346
Amortisation of intangible
customer contracts & relationships 880 950 1,459
---------------- ---------------- -----------------
Adjusted profit (GBP000) (987) 1,990 3,805
---------------- ---------------- -----------------
Weighted average number
of shares used in diluted
earnings per share calculations
('000) 196,547 189,268 190,836
Potentially dilutive share
options and contingent
share consideration ('000) 144 2,070 3,238
---------------- ---------------- -----------------
Weighted average number
of shares used in diluted
earnings per share calculations
('000) 196,691 189,338 194,074
---------------- ---------------- -----------------
Adjusted basic earnings
per share (Pence) (0.50) 1.06 1.99
Adjusted diluted earnings
per share (Pence) (0.50) 1.05 1.96
---------------- ---------------- -----------------
3. Dividends
The below dividends are recorded in the financial
information
6 months 6 months Year ended
ended 30 September ended 30 September 31 March 2023
2023 2022
GBP000 (Unaudited) GBP000 (Unaudited) GBP000 (Audited)
Interim dividend (FY23)
- 0.50p per share - - 937
Final dividend (FY22) -
0.50p per share - - 971
- - 1,908
In addition to the above, a final dividend (FY23) of 0.125p per
share or GBP246,000 was paid in October 2023. The Board are not
proposing to pay an interim dividend in respect of FY24.
4. Distribution of Interim Report
A copy of the interim report will be available shortly on the
Company's website ( www.totallyplc.com ) in accordance with Rule 26
of the AIM Rules for Companies.
This announcement contains inside information for the purposes
of article 7 of the Market Abuse Regulation (EU) 596/2014 as
amended by regulation 11 of the Market Abuse (Amendment) (EU Exit)
Regulations 2019/310. With the publication of this announcement,
this information is now considered to be in the public domain.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IR DBBDBUUDDGXR
(END) Dow Jones Newswires
November 28, 2023 02:00 ET (07:00 GMT)
Totally (LSE:TLY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Totally (LSE:TLY)
Historical Stock Chart
From Apr 2023 to Apr 2024
